Works matching IS 17762596 AND DT 2007 AND VI 2

Results: 35

Effect of cetuximab in recurrent and refractory squamous cell carcinoma of the head and neck (SCCHN): a case report.

Published in:

Targeted Oncology, 2007, v. 2, n. 4, p. 253, doi. 10.1007/s11523-007-0061-6

By:

Schettino, Clorinda;
Bareschino, Maria;
Monaco, Katia;
Orditura, Michele;
Vita, Ferdinando;
Ciardiello, Fortunato

Publication type:

Article

Combining targeted therapies.

Published in:

Targeted Oncology, 2007, v. 2, n. 4, p. 241, doi. 10.1007/s11523-007-0062-5

By:

García-Albeniz, Xabier;
Martinez-Fernandez, Alejandro;
Gascon, Pere

Publication type:

Article

Beyond outstanding results with VEGFR/PDGFR inhibitors in advanced hepatocellular carcinoma: can imaging help where biomarkers keep us waiting?

Published in:

2007

By:

Faivre, S.;
Raymond, E.

Publication type:

Editorial

Molecular targeted therapy for advanced hepatocellular carcinoma.

Published in:

Targeted Oncology, 2007, v. 2, n. 4, p. 199, doi. 10.1007/s11523-007-0058-1

By:

Shen, Ying;
Hsu, Chiun;
Cheng, Ann

Publication type:

Article

New angiogenic agents and non-small cell lung cancer: current results and future development.

Published in:

Targeted Oncology, 2007, v. 2, n. 4, p. 211, doi. 10.1007/s11523-007-0060-7

By:

Rossi, Antonio;
Maione, Paolo;
Ferrara, Carmine;
Gaizo, Filomena;
Guerriero, Ciro;
Nicolella, Dario;
Palazzolo, Giovanni;
Falanga, Marzia;
Colantuoni, Giuseppe;
Gridelli, Cesare

Publication type:

Article

Targeted therapy in hormone refractory prostate cancer.

Published in:

Targeted Oncology, 2007, v. 2, n. 4, p. 235, doi. 10.1007/s11523-007-0063-4

By:

Burbridge, S.;
Chowdhury, S.;
Harper, P.

Publication type:

Article

The intersection of sunitinib with the immunosuppressive microenvironment of renal cell carcinoma: implications for future therapeutics.

Published in:

Targeted Oncology, 2007, v. 2, n. 4, p. 225, doi. 10.1007/s11523-007-0064-3

By:

Salas, Renee;
Finke, James;
Rini, Brian

Publication type:

Article

Radioimmunotherapy (RIT) in non-Hodgkin lymphoma.

Published in:

Targeted Oncology, 2007, v. 2, n. 3, p. 173, doi. 10.1007/s11523-007-0057-2

By:

Kyle, Fiona;
Pettengell, Ruth

Publication type:

Article

Targeted therapy in advanced colorectal cancer, an update.

Published in:

Targeted Oncology, 2007, v. 2, n. 3, p. 165, doi. 10.1007/s11523-007-0052-7

By:

Tol, J.;
Punt, C.

Publication type:

Article

Role of the endothelins and endothelin receptors in cancer cell signaling and angiogenesis.

Published in:

Targeted Oncology, 2007, v. 2, n. 3, p. 181, doi. 10.1007/s11523-007-0056-3

By:

Ghoul, Aïda;
Serova, Maria;
Tourneau, Christophe;
Aïssat, Nasredine;
Hammel, Pascal;
Raymond, Eric;
Faivre, Sandrine

Publication type:

Article

The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts.

Published in:

Targeted Oncology, 2007, v. 2, n. 3, p. 135, doi. 10.1007/s11523-007-0054-5

By:

Behrens, Diana;
Lykkesfeldt, Anne;
Fichtner, Iduna

Publication type:

Article

Normalization, inhibition, rarefaction?

Published in:

2007

By:

Morère, Jean-François

Publication type:

Editorial

Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient.

Published in:

Targeted Oncology, 2007, v. 2, n. 3, p. 193, doi. 10.1007/s11523-007-0050-9

By:

Medioni, Jacques;
Cojocarasu, Oana;
Banu, Eugeniu;
Cassar-Queudeville, Alexia;
Halimi, Philippe;
Oudard, Stéphane

Publication type:

Article

Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment.

Published in:

Targeted Oncology, 2007, v. 2, n. 3, p. 145, doi. 10.1007/s11523-007-0053-6

By:

Akagi, Kiwamu;
Sakai, Hiroshi;
Sudo, Junko;
Hommura, Yasuo;
Kurimoto, Futoshi;
Komagata, Hiroshi;
Akiyama, Hirohiko;
Yoneda, Shuichi

Publication type:

Article

VEGF: a key therapeutic target for the treatment of cancer-insights into its role and pharmacological inhibition.

Published in:

Targeted Oncology, 2007, v. 2, n. 3, p. 153, doi. 10.1007/s11523-007-0051-8

By:

Tobelem, Gérard

Publication type:

Article

Second-line therapy with gefitinib in combination with docetaxel for advanced non-small cell lung cancer: a phase II randomized study.

Published in:

Targeted Oncology, 2007, v. 2, n. 2, p. 63, doi. 10.1007/s11523-007-0042-9

By:

Robinet, G.;
Barlesi, F.;
Fournel, P.;
Berard, H.;
Corre, R.;
Vergnenegre, A.;
Falchero, L.;
Souquet, P-J.;
Tisseron-Carrasco, A.;
Chouaid, C.

Publication type:

Article

Epithelial growth factor receptor (EGFR) pathway and renal cell carcinoma.

Published in:

Targeted Oncology, 2007, v. 2, n. 2, p. 99, doi. 10.1007/s11523-007-0044-7

By:

Ravaud, Alain;
Clermont, Henri;
Pasticier, Gilles;
Smith, Denis;
Vendrely, Véronique;
Maire, Jean

Publication type:

Article

Targeted therapy for small cell lung cancer.

Published in:

Targeted Oncology, 2007, v. 2, n. 2, p. 89, doi. 10.1007/s11523-007-0045-6

By:

Ganti, Apar;
Panwalkar, Amit

Publication type:

Article

Highlights from the pharmacology and molecular mechanisms group annual meeting.

Published in:: Targeted Oncology, 2007, v. 2, n. 2, p. 121, doi. 10.1007/s11523-007-0046-5
Publication type:: Article

Lapatinib: a novel dual tyrosine kinase inhibitor.

Published in:

Targeted Oncology, 2007, v. 2, n. 2, p. 107, doi. 10.1007/s11523-007-0047-4

By:

Chowdhury, Simon;
Pickering, Lisa;
Ellis, Paul

Publication type:

Article

The value of innovation: the economics of targeted drugs for cancer.

Published in:

Targeted Oncology, 2007, v. 2, n. 2, p. 113, doi. 10.1007/s11523-007-0043-8

By:

Tigue, Cara;
Fitzner, Karen;
Alkhatib, Motasem;
Schmid, Eric;
Bennett, Charles

Publication type:

Article

Targeted therapies in head and neck cancer.

Published in:

Targeted Oncology, 2007, v. 2, n. 2, p. 73, doi. 10.1007/s11523-007-0048-3

By:

Specenier, Pol;
Vermorken, Jan

Publication type:

Article

Have we made progress with biological agents in metastatic colorectal cancer?

Published in:

2007

By:

Van Cutsem, Eric

Publication type:

Editorial

28th winter meeting of the EORTC-PAMM group Max Delbrück center for molecular medicine.

Published in:: Targeted Oncology, 2007, v. 2, p. S4, doi. 10.1007/s11523-007-0002-4
Publication type:: Article

Invited speakers.

Published in:: Targeted Oncology, 2007, v. 2, p. S8, doi. 10.1007/s11523-007-0003-3
Publication type:: Article

Author index.

Published in:: Targeted Oncology, 2007, v. 2, p. S65, doi. 10.1007/s11523-007-0004-2
Publication type:: Article

Proffered papers and posters.

Published in:: Targeted Oncology, 2007, v. 2, p. S20, doi. 10.1007/s11523-007-0005-1
Publication type:: Article

A new service.

Published in:: 2007
Publication type:: Editorial

Renewed hope in the treatment of renal cell carcinoma.

Published in:

2007

By:

Chowdhury, Simon;
Spicer, James;
Harper, Peter

Publication type:

Editorial

Targeted therapies in T-cell malignancies.

Published in:

Targeted Oncology, 2007, v. 2, n. 1, p. 39, doi. 10.1007/s11523-006-0035-0

By:

Leung, Anskar;
Liang, Raymond

Publication type:

Article

Lymph node metastasis as a new target for cancer treatment.

Published in:

Targeted Oncology, 2007, v. 2, n. 1, p. 49, doi. 10.1007/s11523-006-0037-y

By:

Saintigny, Pierre;
Morère, Jean-François;
Breau, Jean-Luc;
Bernaudin, Jean-François;
Kraemer, Michel

Publication type:

Article

Somatic von Hippel-Lindau ( VHL) gene analysis and clinical outcome under antiangiogenic treatment in metastatic renal cell carcinoma: preliminary results.

Published in:

Targeted Oncology, 2007, v. 2, n. 1, p. 3, doi. 10.1007/s11523-006-0039-9

By:

Gad, Sophie;
Sultan-Amar, Valentine;
Meric, Jean-Baptiste;
Izzedine, Hassan;
Khayat, David;
Richard, Stéphane;
Rixe, Olivier

Publication type:

Article

Mechanisms of resistance to EGFR inhibitors.

Published in:

Targeted Oncology, 2007, v. 2, n. 1, p. 31, doi. 10.1007/s11523-006-0038-x

By:

Bianco, Roberto;
Gelardi, Teresa;
Damiano, Vincenzo;
Ciardiello, Fortunato;
Tortora, Giampaolo

Publication type:

Article

Targeted therapies for renal cell carcinoma.

Published in:

Targeted Oncology, 2007, v. 2, n. 1, p. 7, doi. 10.1007/s11523-006-0041-2

By:

Villanueva, Mary;
Hauke, Ralph

Publication type:

Article

New multitargeted treatments with antiangiogenic and antitumor activity: focus on sunitinib.

Published in:

Targeted Oncology, 2007, v. 2, n. 1, p. 17, doi. 10.1007/s11523-006-0040-3

By:

Dalgleish, A.;
Copier, J.

Publication type:

Article